Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma

Wei, K; Li, M; Zoller, M; Wang, M; Mehrabi, A; Hoffmann, K

Hoffmann, K (reprint author), Ruprecht Karls Univ Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.

CELL DEATH & DISEASE, 2019; 10 ():

Abstract

Clinical treatment options for human cholangiocarcinoma (CC) are limited. c-MET, a high-affinity receptor for hepatocyte growth factor (HGF), is dereg......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索